{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:53:36Z","timestamp":1761490416771},"reference-count":31,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,14]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>GM-K562 admixed leukemia cell vaccination after allogeneic HSCT has biologic activity in MDS\/AML. Postvaccination antibody response to angiopoeitin-2 is associated with improved outcomes.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017009084","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T01:40:19Z","timestamp":1510710019000},"page":"2269-2279","source":"Crossref","is-referenced-by-count":20,"title":["Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT"],"prefix":"10.1182","volume":"1","author":[{"given":"Vincent T.","family":"Ho","sequence":"first","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haesook T.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computation Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Bavli","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Mihm","sequence":"additional","affiliation":[{"name":"Department of Dermatology and"},{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Pozdnyakova","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Piesche","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"},{"name":"Biomedical Research Laboratories, Medicine Faculty, Catholic University of Maule, Talca, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Daley","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas C.","family":"Souders","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Cutler","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Koreth","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin P.","family":"Alyea","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Dranoff","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Soiffer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"issue":"12","key":"2019101004194487200_B1","first-page":"1653","article-title":"Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens","volume":"91","author":"Greiner","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"2019101004194487200_B2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2249.2007.03383.x","article-title":"Translational mini-review series on vaccines: peptide vaccines for myeloid leukaemias","volume":"148","author":"Barrett","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"2019101004194487200_B3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/79526","article-title":"Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia","volume":"6","author":"Molldrem","year":"2000","journal-title":"Nat Med"},{"issue":"6","key":"2019101004194487200_B4","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood-2007-03-076844","article-title":"Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia","volume":"110","author":"Rezvani","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019101004194487200_B5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood-2005-03-1259","article-title":"Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation","volume":"107","author":"Rousseau","year":"2006","journal-title":"Blood"},{"issue":"11","key":"2019101004194487200_B6","article-title":"PR1 vaccine elicited immunological response after hematopoietic stem cell transplantation is associated with better clinical response and event-free survival [abstract]","volume":"110","author":"Quazilbash","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019101004194487200_B7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.21127","article-title":"Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia","volume":"83","author":"Kitawaki","year":"2008","journal-title":"Am J Hematol"},{"issue":"7","key":"2019101004194487200_B8","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1073\/pnas.0307298101","article-title":"IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells","volume":"101","author":"Klebanoff","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019101004194487200_B9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2003-09-3344","article-title":"Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation","volume":"105","author":"Alpdogan","year":"2005","journal-title":"Blood"},{"issue":"12","key":"2019101004194487200_B10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbmt.2005.08.032","article-title":"Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Reddy","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2019101004194487200_B11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20071681","article-title":"Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets","volume":"205","author":"Sport\u00e8s","year":"2008","journal-title":"J Exp Med"},{"issue":"5","key":"2019101004194487200_B12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood-2015-10-672345","article-title":"Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD","volume":"127","author":"Alho","year":"2016","journal-title":"Blood"},{"issue":"22","key":"2019101004194487200_B13","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.95.22.13141","article-title":"Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma","volume":"95","author":"Soiffer","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"2019101004194487200_B14","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1200\/JCO.2003.07.005","article-title":"Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma","volume":"21","author":"Soiffer","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019101004194487200_B15","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"2019101004194487200_B16","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1073\/pnas.0603503103","article-title":"Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity","volume":"103","author":"Jinushi","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019101004194487200_B17","article-title":"A phase I study of vaccination with lethally irradiated, autologous myeloblasts engineered by adenoviral mediated gene transfer to secrete human granulocyte-macrophage colony stimulating factor [abstract]","volume":"98","author":"DeAngelo","year":"2001","journal-title":"Blood"},{"key":"2019101004194487200_B18","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.441.441","article-title":"Posttransplant immunotherapy with a GM-CSF based tumor vaccine (GVAX) following autologous stem cell transplant (ASCT) for acute myeloid leukemia (AML) [abstract]","author":"DeAngelo","year":"2004"},{"issue":"1","key":"2019101004194487200_B19","first-page":"162","article-title":"Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation","volume":"61","author":"Teshima","year":"2001","journal-title":"Cancer Res"},{"issue":"37","key":"2019101004194487200_B20","doi-asserted-by":"crossref","first-page":"15825","DOI":"10.1073\/pnas.0908358106","article-title":"Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation","volume":"106","author":"Ho","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019101004194487200_B21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1158\/1078-0432.CCR-14-1956","article-title":"Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions","volume":"21","author":"Piesche","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2019101004194487200_B22","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4161\/onci.20954","article-title":"Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients","volume":"1","author":"Brusic","year":"2012","journal-title":"OncoImmunology"},{"issue":"9","key":"2019101004194487200_B23","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1038\/bcj.2013.44","article-title":"Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562\/GVAX immunotherapy","volume":"3","author":"Qin","year":"2013","journal-title":"Blood Cancer J"},{"issue":"9","key":"2019101004194487200_B24","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2009-02-205278","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)","volume":"114","author":"Borrello","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2019101004194487200_B25","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1172\/JCI69098","article-title":"Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells","volume":"123","author":"Burkhardt","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"2019101004194487200_B26","first-page":"1140","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1998","journal-title":"Ann Stat"},{"issue":"7","key":"2019101004194487200_B27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bbmt.2009.03.017","article-title":"Comparison of tacrolimus and sirolimus (Tac\/Sir) versus tacrolimus, sirolimus, and mini-methotrexate (Tac\/Sir\/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation","volume":"15","author":"Ho","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2019101004194487200_B28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1200\/JCO.2003.03.091","article-title":"Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma","volume":"21","author":"Salgia","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019101004194487200_B29","doi-asserted-by":"crossref","first-page":"8ra19","DOI":"10.1126\/scitranslmed.3000359","article-title":"In situ regulation of DC subsets and T cells mediates tumor regression in mice","volume":"1","author":"Ali","year":"2009","journal-title":"Sci Transl Med"},{"issue":"2","key":"2019101004194487200_B30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1158\/2326-6066.CIR-14-0126","article-title":"Vaccines combined with immune checkpoint antibodies promote cytotoxic T-cell activity and tumor eradication","volume":"4","author":"Ali","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"2019101004194487200_B31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.3071","article-title":"Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy","volume":"33","author":"Kim","year":"2015","journal-title":"Nat Biotechnol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/24\/2269\/879018\/advances009084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/24\/2269\/879018\/advances009084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T09:44:25Z","timestamp":1659865465000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/24\/2269\/16216\/Vaccination-with-autologous-myeloblasts-admixed"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":31,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2017,11,14]]},"published-print":{"date-parts":[[2017,11,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017009084","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]}}}